Figure 7.
Electrophysiological measures of motor unit function following targeted Smn-deletion and restoration. (A) Compound muscle action potential (CMAP) at P21 in mice with Smn-deletion. Compound muscle action potential (CMAP) amplitudes at postnatal day 21 (P21) were reduced in ChAT-Cre Smn-deletion (n = 9, 20.4 ± 1.9, P < 0.05) and Nestin-Cre + ChAT-Cre Smn-deletion (n = 13, 26.1 ± 2.1, P = <0.05) but not Nestin-Cre Smn-deletion mice (n = 14, 35.7 ± 3.7) compared with controls (n = 13, 44.0 ± 2.9 mV). CMAP amplitudes in ChAT-Cre Smn-deletion mice were reduced compared with Nestin-Cre Smn-deletion mice (P < 0.05). (B) Motor unit number estimation (MUNE) at P21 in mice with Smn-deletion. Motor unit number estimates (MUNE) at P21 were reduced in ChAT-Cre Smn-deletion (n = 9, 142 ± 22), Nestin-Cre + ChAT-Cre Smn-deletion (n = 13, 117 ± 15), and Nestin-Cre Smn-deletion mice (n = 14, 179 ± 24) compared with controls (n = 13, 283 ± 15) (P < 0.001). (C) Electromyography of limb muscles of mice with Smn deletion. Fibrillations were noted in both ChAT-Cre Smn-deletion (four of five mice) and Nestin-Cre + ChAT-Cre Smn-deletion mice (six of seven mice) but are absent in Nestin-Cre Smn-deletion mice (zero of six) and control mice (zero of five) (P < 0.05). (D) CMAP amplitudes at P12 in mice with Smn-restoration. CMAP amplitudes at P12 in mice with Nestin-Cre + ChAT-Cre Smn-restoration (n = 9, 23.2 ± 3.3) were similar to control mice (n = 13, 24.8 ± 1.2 mV). Conversely, compared with control mice, CMAP amplitudes were reduced in mice with Nestin-Cre-restoration of Smn (n = 8, 17.3 ± 1.1 mV) and in SMA mice with no Cre (i.e. no Smn-restoration) (n = 12, 17.1 ± 0.8 mV) (P < 0.05). CMAP amplitudes were reduced though does not reach statistical significance in SMA mice with ChAT-Cre-restoration of Smn (n = 14, 18.8 ± 1.2 mV). (E) MUNE at P12 in mice with Smn-restoration. MUNE at P12 in mice with ChAT-Cre Smn-restoration (n = 14, 187 ± 16) and Nestin-Cre + ChAT-Cre Smn-restoration (n = 9, 201 ± 22) are similar to controls (n = 13, 196 ± 16, P = 0.962), but MUNE are reduced in mice with Nestin-Cre-restoration of Smn (n = 8, 118 ± 16) and SMA mice with no Cre (i.e. no Smn-restoration) (119 ± 9) (P < 0.05). Compared with mice with Nestin-Cre-restoration of Smn, MUNE at P12 in mice with ChAT-Cre Smn-restoration (P = 0.042) and Nestin-Cre + ChAT-Cre Smn-restoration (P = 0.024) are increased. Similarly, compared with SMA mice with no Cre, MUNE in mice with ChAT-Cre Smn-restoration (P = 0.031) and Nestin-Cre + ChAT-Cre Smn-restoration (P = 0.017) are increased. (*P ≤ 0.05, ***P ≤ 0.001).